Document is current

Any future updates will be listed below

183 Cancer-mutation-specific T cells: novel immunotherapy approach for low mutational burden patients

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0183

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark